- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-tetramer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.5: 4 residues within 4Å:- Chain A: N.193, T.195, Q.282, E.283
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:N.193, A:E.283, A:E.283
- Water bridges: A:T.195
NAG.6: 6 residues within 4Å:- Chain A: I.293, N.295, M.322, S.323, T.324, R.570
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.570
- Water bridges: A:N.295
NAG.7: 4 residues within 4Å:- Chain A: V.52, N.59, S.60, S.61
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.54, A:S.61
NAG.9: 4 residues within 4Å:- Chain B: Y.57, N.59, S.60, S.61
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:N.59
- Hydrogen bonds: B:S.61
- Water bridges: B:Y.57
NAG.10: 1 residues within 4Å:- Chain B: N.124
No protein-ligand interaction detected (PLIP)NAG.11: 3 residues within 4Å:- Chain B: W.161, V.253, N.255
No protein-ligand interaction detected (PLIP)NAG.12: 6 residues within 4Å:- Chain B: I.293, N.295, M.322, S.323, T.324, R.570
3 PLIP interactions:3 interactions with chain B- Water bridges: B:N.295, B:N.295, B:R.570
NAG.13: 4 residues within 4Å:- Chain B: N.193, T.195, Q.282, E.283
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:N.193, B:E.283
- Water bridges: B:T.195
NAG.17: 2 residues within 4Å:- Chain C: I.122, N.124
No protein-ligand interaction detected (PLIP)NAG.18: 3 residues within 4Å:- Chain C: W.161, V.253, N.255
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.255
NAG.19: 6 residues within 4Å:- Chain C: I.293, N.295, M.322, S.323, T.324, R.570
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:N.295
- Water bridges: C:S.323, C:T.324
NAG.21: 2 residues within 4Å:- Chain D: R.121, N.124
No protein-ligand interaction detected (PLIP)NAG.22: 4 residues within 4Å:- Chain D: N.193, T.195, Q.282, E.283
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.193, D:T.195, D:E.283
- Water bridges: D:T.195
NAG.23: 3 residues within 4Å:- Chain D: W.161, V.253, N.255
No protein-ligand interaction detected (PLIP)NAG.24: 6 residues within 4Å:- Chain D: I.293, N.295, M.322, S.323, T.324, R.570
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:R.570
- Water bridges: D:N.295
- 4 x 6RL: 2-[[6-[(3~{R})-3-azanylpiperidin-1-yl]-3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]methyl]-4-fluoranyl-benzenecarboni trile(Non-covalent)
6RL.8: 15 residues within 4Å:- Chain A: R.99, E.179, E.180, F.331, Y.521, W.603, S.604, Y.605, V.630, W.633, Y.636, Y.640, N.684, V.685, H.714
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:F.331, A:Y.605, A:V.630, A:Y.636, A:Y.640, A:V.685
- Hydrogen bonds: A:R.99, A:E.179, A:Y.521, A:Y.605
- Water bridges: A:R.99, A:S.604, A:Y.636
- pi-Stacking: A:Y.640
6RL.14: 15 residues within 4Å:- Chain B: R.99, E.179, E.180, F.331, Y.521, W.603, S.604, Y.605, V.630, W.633, Y.636, Y.640, N.684, V.685, H.714
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:F.331, B:Y.605, B:V.630, B:Y.636, B:Y.636, B:Y.640, B:V.685
- Hydrogen bonds: B:E.179, B:Y.605
- Water bridges: B:R.99, B:S.604
- pi-Stacking: B:Y.640
6RL.20: 15 residues within 4Å:- Chain C: R.99, E.179, E.180, F.331, Y.521, W.603, S.604, Y.605, V.630, W.633, Y.636, Y.640, N.684, V.685, H.714
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:F.331, C:Y.605, C:V.630, C:Y.636, C:V.685
- Hydrogen bonds: C:R.99, C:E.179, C:E.179, C:Y.605
- Water bridges: C:S.604
- pi-Stacking: C:Y.640
6RL.25: 15 residues within 4Å:- Chain D: R.99, E.179, E.180, F.331, Y.521, W.603, S.604, Y.605, V.630, W.633, Y.636, Y.640, N.684, V.685, H.714
13 PLIP interactions:13 interactions with chain D- Hydrophobic interactions: D:F.331, D:Y.605, D:V.630, D:Y.636, D:V.685
- Hydrogen bonds: D:R.99, D:E.179, D:E.179, D:Y.605, D:Y.636
- Water bridges: D:R.99, D:S.604
- pi-Stacking: D:Y.640
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grimshaw, C.E. et al., Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism. Plos One (2016)
- Release Date
- 2016-07-13
- Peptides
- Dipeptidyl peptidase 4: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-tetramer
- Ligands
- 6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x 6RL: 2-[[6-[(3~{R})-3-azanylpiperidin-1-yl]-3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]methyl]-4-fluoranyl-benzenecarboni trile(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grimshaw, C.E. et al., Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism. Plos One (2016)
- Release Date
- 2016-07-13
- Peptides
- Dipeptidyl peptidase 4: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D